Company Filing History:
Years Active: 1988-2017
Title: **Jack D. Keene: Innovating in Gene Expression Profiling**
Introduction
Jack D. Keene, based in Durham, NC, is a distinguished inventor with a notable portfolio comprising 18 patents. His contributions primarily lie in the realm of molecular biology, particularly involving gene expression and regulatory RNA.
Latest Patents
Among his latest patents, Keene has developed methods for in vivo identification of endogenous mRNA targets of microRNAs. This innovative approach entails generating a gene expression profile of noncoding regulatory RNA (ncRNA) within live cells. The method involves partitioning mRNA-protein complexes to identify ncRNA within these complexes, thus creating a comprehensive gene expression profile. Another significant patent focuses on the identification of functionally related genes and drug targets. This invention evaluates mRNA and protein targets associated with mRNP complexes, which can play a critical role in treating diseases linked to specific physiological pathways.
Career Highlights
Throughout his career, Keene has made impactful advancements in the field of molecular biology. His work at reputable institutions, particularly Duke University, has established him as a leading figure in the study of gene expression and regulatory mechanisms.
Collaborations
Jack D. Keene has collaborated with notable colleagues such as Scott A. Tenenbaum and Craig C. Carson. Together, their efforts have significantly contributed to the understanding and applications of RNA mechanisms in various biological contexts.
Conclusion
With a strong foundation in molecular biology and a commitment to innovation, Jack D. Keene continues to influence the field through his patents and collaborative projects. His work not only deepens our understanding of gene expression but also opens avenues for potential therapeutic interventions in related diseases.